Healthcare provider profile · identity verified

Robert Harris Dudley, MD

Family Practice · DELRAY BEACH, FL · NPI 1619973328

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	573	200
Alprazolam	Alprazolam	456	117
Levothyroxine Sodium	Levothyroxine Sodium	279	92
Amlodipine Besylate	Amlodipine Besylate	254	82
Rosuvastatin Calcium	Rosuvastatin Calcium	235	93
Lisinopril	Lisinopril	190	61
Metoprolol Succinate	Metoprolol Succinate	169	60
Losartan Potassium	Losartan Potassium	163	62
Tramadol Hcl	Tramadol Hcl	158	66
Zolpidem Tartrate	Zolpidem Tartrate	149	44
Metformin Hcl	Metformin Hcl	143	51
Hydrochlorothiazide	Hydrochlorothiazide	142	49
Pantoprazole Sodium	Pantoprazole Sodium	136	46
Methylprednisolone	Methylprednisolone	122	97
Omeprazole	Omeprazole	117	36
Tamsulosin Hcl	Tamsulosin Hcl	103	43
Simvastatin	Simvastatin	100	32
Carvedilol	Carvedilol	98	31
Trazodone Hcl	Trazodone Hcl	96	46
Gabapentin	Gabapentin	93	34
Ozempic	Semaglutide	81	24
Sertraline Hcl	Sertraline Hcl	80	26
Azithromycin	Azithromycin	75	64
Eliquis	Apixaban	75	19
Escitalopram Oxalate	Escitalopram Oxalate	72	27
Temazepam	Temazepam	70	16
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	66	22
Triamcinolone Acetonide	Triamcinolone Acetonide	61	43
Lorazepam	Lorazepam	59	20
Synthroid	Levothyroxine Sodium	56	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	55	14
Metoprolol Tartrate	Metoprolol Tartrate	52	20
Allopurinol	Allopurinol	50	17
Diazepam	Diazepam	48	15
Fluticasone Propionate	Fluticasone Propionate	46	23
Clonazepam	Clonazepam	45	20
Potassium Chloride	Potassium Chloride	45	15
Memantine Hcl	Memantine Hcl	40	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	40	30
Atenolol	Atenolol	39	16
Albuterol Sulfate Hfa	Albuterol Sulfate	38	22
Cephalexin	Cephalexin	37	33
Paxlovid	Nirmatrelvir/Ritonavir	37	37
Baclofen	Baclofen	36	12
Doxycycline Hyclate	Doxycycline Hyclate	35	31
Ondansetron Odt	Ondansetron	35	23
Buspirone Hcl	Buspirone Hcl	34	suppressed
Duloxetine Hcl	Duloxetine Hcl	34	12
Glipizide	Glipizide	34	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	13
Prednisone	Prednisone	34	23
Donepezil Hcl	Donepezil Hcl	33	11
Furosemide	Furosemide	33	15
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	33	24
Quetiapine Fumarate	Quetiapine Fumarate	33	11
Clopidogrel	Clopidogrel Bisulfate	31	14
Famotidine	Famotidine	31	14
Metformin Hcl Er	Metformin Hcl	31	11
Minoxidil	Minoxidil	31	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	30	suppressed
Mounjaro	Tirzepatide	30	suppressed
Xarelto	Rivaroxaban	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	23
Ezetimibe	Ezetimibe	29	12
Amoxicillin	Amoxicillin	28	24
Montelukast Sodium	Montelukast Sodium	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	11
Pravastatin Sodium	Pravastatin Sodium	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	15
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Finasteride	Finasteride	25	12
Nifedipine Er	Nifedipine	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	14
Propranolol Hcl	Propranolol Hcl	25	suppressed
Bupropion Xl	Bupropion Hcl	24	13
Celecoxib	Celecoxib	24	suppressed
Naproxen	Naproxen	24	11
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	23	suppressed
Entresto	Sacubitril/Valsartan	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	11
Valsartan	Valsartan	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Acyclovir	Acyclovir	21	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	12
Pregabalin	Pregabalin	20	suppressed
Terbinafine Hcl	Terbinafine Hcl	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Imiquimod	Imiquimod	19	16
Lamotrigine	Lamotrigine	19	suppressed
Modafinil	Modafinil	19	suppressed
Fluconazole	Fluconazole	18	13
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Mupirocin	Mupirocin	18	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Dexmethylphenidate Hcl	Dexmethylphenidate Hcl	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Meloxicam	Meloxicam	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Estradiol	Estradiol	14	12
Levofloxacin	Levofloxacin	14	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Ramipril	Ramipril	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Adderall	Dextroamphetamine/Amphetamine	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Triazolam	Triazolam	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Linzess	Linaclotide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error